1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 1, 2023.
The trade is 33.3% of the 30,000,000 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider Bakelai Capital Ltd sold about $10.0M of QDMI on Aug 1, 2024, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 1, 2023.
The trade is 14.3% of the 26,240,754 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider Bakelai Capital Ltd sold about $3.8M of QDMI on Aug 1, 2024, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 1, 2023.
The trade is 26.3% of the 38,000,000 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider Ruiyin Capital Ltd sold about $10.0M of QDMI on Aug 1, 2024, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 1, 2023.
The trade is 6.7% of the 26,240,754 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider Ruiyin Capital Ltd sold about $1.8M of QDMI on Aug 1, 2024, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 98.7% of the 121,588,100 shares held after it.
2 other insiders bought within 30 days.
Insider activity: CEO and President Zheng Huihe bought about $1.2M of QDMI on Feb 1, 2023, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$26.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM QDMI
FY Mar 2026
$21.5M
FY Mar 2025
$8.4M
FY Mar 2024
$6.4M
FY Mar 2023
$1.1M
FY Mar 2022
$69.0K
Jun 2026
$8.4M
Mar 2026
$9.1M
Dec 2025
$4.8M
Sep 2025
$4.0M
Jun 2025
$3.6M
Mar 2025
$4.8M
Dec 2024
$1.6M
Sep 2024
$1.0M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM QDMI
FY Mar 2026
n/a
FY Mar 2025
+57.5%
FY Mar 2024
+24.6%
FY Mar 2023
+3.9%
FY Mar 2022
n/a
Jun 2026
+37.6%
Mar 2026
+56.7%
Dec 2025
+26.6%
Sep 2025
-28.0%
Jun 2025
+51.5%
Mar 2025
+66.4%
Dec 2024
+44.0%
Sep 2024
+47.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM QDMI
FY Mar 2026
$1.7M
FY Mar 2025
$4.0M
FY Mar 2024
$2.1M
FY Mar 2023
-$5.7K
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity QDMI
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt QDMI
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity QDMI
FY Mar 2026
n/a
FY Mar 2025
+78.7%
FY Mar 2024
+59.9%
FY Mar 2023
+7.9%
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+64.5%
Sep 2025
+64.6%
Jun 2025
+85.3%
Mar 2025
+78.7%
Dec 2024
+40.7%
Sep 2024
+35.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets QDMI
FY Mar 2026
n/a
FY Mar 2025
+58.5%
FY Mar 2024
+35.1%
FY Mar 2023
+2.6%
FY Mar 2022
-179.4%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+45.6%
Sep 2025
+44.3%
Jun 2025
+62.0%
Mar 2025
+58.5%
Dec 2024
+26.8%
Sep 2024
+19.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital QDMI
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed QDMI
FY Mar 2026
n/a
FY Mar 2025
+95.1%
FY Mar 2024
+67.2%
FY Mar 2023
+6.8%
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+73.4%
Sep 2025
+78.0%
Jun 2025
+100.3%
Mar 2025
+95.1%
Dec 2024
+49.7%
Sep 2024
+40.9%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.30x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing QDMI
FY Mar 2026
82.26x
FY Mar 2025
119.77x
FY Mar 2024
5,436.60x
FY Mar 2023
340.00x
FY Mar 2022
n/a
Jun 2026
8.08x
Mar 2026
82.26x
Dec 2025
64.46x
Sep 2025
146.70x
Jun 2025
134.14x
Mar 2025
119.77x
Dec 2024
448.71x
Sep 2024
1,930.00x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value QDMI
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-2.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield QDMI
FY Mar 2026
+0.3%
FY Mar 2025
+0.0%
FY Mar 2024
+0.1%
FY Mar 2023
-0.8%
FY Mar 2022
n/a
Jun 2026
-3.0%
Mar 2026
+0.3%
Dec 2025
+1.9%
Sep 2025
+0.0%
Jun 2025
+0.0%
Mar 2025
+0.0%
Dec 2024
+0.0%
Sep 2024
+0.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.29x
P/E over trailing EPS growth of 36%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing QDMI
FY Mar 2026
1.25x
FY Mar 2025
0.02x
FY Mar 2024
5,311,841,679,769,234.00x
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
0.23x
Mar 2026
1.25x
Dec 2025
0.20x
Sep 2025
0.21x
Jun 2025
0.02x
Mar 2025
0.02x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
Revenue growth, YoY+156.2% · 97 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
85
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 138
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+7.3% · 70 pct, sector of 110
5 not measured: Profitability, Financial health, Insider conviction, Institutional and government, US patents
Profitability needs 2 of 4 inputs, 0 present: the filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.